XML 61 R41.htm IDEA: XBRL DOCUMENT v3.22.4
Supplementary Information (Tables)
12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Other Nonoperating Income (Expense)
Other Income (Expense) - NetFor the Year Ended December 31,
(In millions)202220212020
Interest income$124 $77 $56 
Equity in earnings (losses) of affiliates - net20 14 — 
Net gain (loss) on sales of businesses and other assets1
18 21 (2)
Net exchange gains (losses)2
(229)(54)(174)
Non-operating pension and other post employment benefit credits (costs)3
163 1,318 368 
Miscellaneous income (expenses) - net4
(156)(28)(36)
Other income (expense) - net$(60)$1,348 $212 
1.    The years ended December 31, 2022 and 2021 include a gain of $15 million and $19 million, respectively, relating to the sale of a business in the crop protection segment. The year ended December 31, 2020 includes a loss of $(53) million and a gain of $27 million relating to the sale of the La Porte site, for which the company signed an agreement in 2020, and closed during the first quarter of 2021, and the sale of a business in Asia Pacific in the crop protection segment, respectively.
2.    Includes net pre-tax exchange gains (losses) of $(110) million, $(67) million and $(82) million associated with the devaluation of the Argentine peso for the years ended December 31, 2022, 2021 and 2020, respectively.
3.    Includes non-service related components of net periodic benefit credits (costs) (interest cost, expected return on plan assets, amortization of unrecognized gain (loss), amortization of prior service benefit and settlement gain (loss)). 
4.    Includes losses from sale of receivables, tax indemnification adjustments related to changes in indemnification balances as a result of the application of the terms of the Tax Matters Agreement between Corteva and Dow and/or DuPont, and other items. The years ended December 31, 2022 and 2021 also includes the Employee Retention Credit of $9 million and $60 million, respectively, pursuant to the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act as enhanced by the Consolidated Appropriations Act (“CAA”) and American Rescue Plan Act (“ARPA”). The year ended December 31, 2022 also includes estimated settlement reserves of $(87) million, losses associated with a previously held equity investment, legal accruals, settlement cost associated with the Russia Exit, and charges associated with the exit of a non-strategic asset. The year ended December 31, 2021 includes a charge related to a contract termination with a third-party service provider of $(54) million, a gain from the remeasurement of an equity investment of $47 million, and an officer indemnification payment.
Foreign Currency Exchange Gain (Loss)
For the Year Ended December 31,
(In millions)202220212020
Subsidiary Monetary Position Gain (Loss)
Pre-tax exchange gain (loss) $(217)$(72)$(263)
Local tax (expenses) benefits (10)(30)34 
Net after-tax impact from subsidiary exchange gain (loss) $(227)$(102)$(229)
Hedging Program Gain (Loss)
Pre-tax exchange gain (loss) $(12)$18 $89 
Tax (expenses) benefits (4)(21)
Net after-tax impact from hedging program exchange gain (loss) $(7)$14 $68 
Total Exchange Gain (Loss)
Pre-tax exchange gain (loss) $(229)$(54)$(174)
Tax (expenses) benefits(5)(34)13 
Net after-tax exchange gain (loss) $(234)$(88)$(161)
Restrictions on Cash and Cash Equivalents
(In millions)December 31, 2022December 31, 2021
Cash and cash equivalents$3,191 $4,459 
Restricted cash equivalents427 377 
Total cash, cash equivalents and restricted cash equivalents$3,618 $4,836